In the last trading session, 29.34 million Cyclerion Therapeutics Inc (NASDAQ:CYCN) shares changed hands as the company’s beta touched 1.74. With the company’s per share price at $5.32 changed hands at $1.4 or 35.71% during last session, the market valuation stood at $14.41M. CYCN’s last price was a discount, traded about -78.01% off its 52-week high of $9.47. The share price had its 52-week low at $1.27, which suggests the last value was 76.13% up since then. When we look at Cyclerion Therapeutics Inc’s average trading volume, we note the 10-day average is 8.33 million shares, with the 3-month average coming to 4.60 million.

Cyclerion Therapeutics Inc (NASDAQ:CYCN) trade information

Instantly CYCN was in green as seen at the end of in last trading. With action 96.31%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 65.22%, with the 5-day performance at 96.31% in the green. However, in the 30-day time frame, Cyclerion Therapeutics Inc (NASDAQ:CYCN) is 65.22% up. Looking at the short shares, we see there were 14439.0 shares sold at short interest cover period of 0.78 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 36.06%.

CYCN Dividends

Cyclerion Therapeutics Inc is expected to release its next quarterly earnings report in March.

Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 21.90% of Cyclerion Therapeutics Inc shares while 40.41% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 51.74%.